These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3883734)

  • 61. [Molsidomine in exertion angina].
    Witchitz S; Kolsky H; Moisson P
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Molsidomin in stable stress angina].
    González Juanatey JR; Amaro Cendón A; Rubio Alvarez J; Gil de la Peña M
    Med Clin (Barc); 1985 Mar; 84(10):420-1. PubMed ID: 3838784
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of molsidomine on exercise tolerance in patients with coronary heart disease.
    Messin R; Demaret B; Denolin H
    Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of molsidomine and dopamine infusion on the size of canine experimental myocardial infarct.
    Fiedler VB; Buchheim S; Göbel H; Nitz RE
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):314-20. PubMed ID: 6897743
    [No Abstract]   [Full Text] [Related]  

  • 67. [Hemodynamic effects of molsidomine in chronic congestive heart failure].
    Humar F; Maras P; Musitelli G; Camerini F
    G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodynamic changes produced by molsidomine in patients with congestive myocardiopathy.
    Otero F; Fernández Berges DJ; Milei J; Agejas R; Vázquez A; Pautasso E
    Acta Cardiol; 1984; 39(5):353-63. PubMed ID: 6334953
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Active and passive changes in coronary diameter after vasodilation with SIN-1, the active metabolite of molsidomine.
    Schulz W; Kober G; Bernauer R; Kaltenbach M
    Am Heart J; 1985 Mar; 109(3 Pt 2):694-9. PubMed ID: 3838406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical study of the preparation korvatone].
    Charchoglian RA; Esin NN; Belozerov GE
    Sov Med; 1982; (5):15-8. PubMed ID: 7051350
    [No Abstract]   [Full Text] [Related]  

  • 71. [A new family of anti-angina agents].
    Gourgon R; Russo-Marie F; Nicolas G; Witchitz S; Berdeaux A; Tartulier M
    Sem Hop; 1983 Oct; 59(37-38):2627-8. PubMed ID: 6314546
    [No Abstract]   [Full Text] [Related]  

  • 72. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
    Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduction of occlusive coronary artery thrombosis and myocardial ischemia by molsidomine in anesthetized dogs.
    Fiedler VB
    Can J Physiol Pharmacol; 1982 Aug; 60(8):1104-11. PubMed ID: 6897011
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of the effects of molsidomine by cardiac equilibrium blood pool scintigraphy.
    Chevigné M; Rigo P; Kassab A; Kulbertus H
    Am Heart J; 1985 Mar; 109(3 Pt 2):658-61. PubMed ID: 3838403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH; Liu RC; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Double-blind controlled trial of molsidomine in hypertension.
    Milei J; Vazquez A; Lemus J
    Eur J Clin Pharmacol; 1980 Oct; 18(3):231-5. PubMed ID: 6893692
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The classic anti-anginal agents and molsidomine].
    Vacheron A
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():71-5. PubMed ID: 6407452
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Therapy of coronary heart disease with molsidomine].
    Kaliman J; Uhlir H; Klicpera M
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1761-2. PubMed ID: 6796846
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease.
    Ostrowski J; Gaul G; Voegele D; Brockmeier D; Resag K
    Eur J Clin Pharmacol; 1985; 28(5):611-3. PubMed ID: 3899679
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities.
    Messin R; Dubois C; Famaey JP
    Adv Ther; 2008 Nov; 25(11):1200-14. PubMed ID: 19002405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.